期刊文献+

氯沙坦与苯那普利降压及降尿酸作用对比观察 被引量:2

Clinical analysis on the effects of Losartan and Benazapril on blood-pressure and uric acid
下载PDF
导出
摘要 目的:比较氯沙坦与苯那普利降压及降尿酸作用。方法:将60例原发性高血压伴高尿酸血症患者随机分成两组,分别给予氯沙坦50mg/d和苯那普利10mg/d,疗程4周。观察两组的降压效果及对血尿酸水平的影响。结果:氯沙坦组治疗后与治疗前比较,血压、血尿酸均显著下降(P<0.05)。苯那普利组治疗后血压显著下降(P<0.05),血尿酸水平治疗前后无显著性差异(P>0.05)。结论:氯沙坦与苯那普利降压作用相似;氯沙坦除有降压作用外,还可降低血尿酸;高血压伴高尿酸血症的患者,氯沙坦为首选药物。 Objective: To compare the effects of Losartan and Benazapril in decreasing bloodpressure and uric acid. Methods, 60 patients suffering from primary hypertension accompanied with hyerurecemia were divided into two groups at random. The two groups are respectively given Losartan 50mg,/d and Benazapril 10mg/d for 4 weeks. Then, make an observation of decreasing blood-pressure and the level of uric acid. Results: Blood-pressure and blood uric acid of the group taking Losartan were significantly decreased(P〈0. 05). Blood-pressure of the group taking Benazapril was also decreased(P〈 0. 05), but blood uric acid level kept the same(P〉0.05). Conclusions Losartan has not only the same effect on hypertension as Benazapril. but also an effect on hyerurecemia. It is the first choice for the hypertension patients with hyerurecemia.
出处 《陕西医学杂志》 CAS 北大核心 2006年第5期598-599,共2页 Shaanxi Medical Journal
关键词 高血压 并发症 尿酸 药物疗法 血管舒张药 氯沙坦 苯那普利 Hypertension/complications Uric acid/drug therapy Vasodilator agents/ therapeutic use Comparative study
  • 相关文献

参考文献5

  • 1徐云飞.206例伴高尿酸血症的原发性高血压患者4年观察[J].中国基层医药,2004,11(7):874-874. 被引量:9
  • 2马洪山,刘艳春,张晓明.缬沙坦治疗高血压病患者伴血尿酸增高40例临床观察[J].中国药物与临床,2003,3(3):265-266. 被引量:8
  • 3De-Rosa ML, Cardace P,Possi M ,et al. Comparative effects of chronic ACE inhibition and AT, receptor blocked losartan on cardiac hypetrophy and renal function in hypertensive patients. J Hum Hypertens,2002,16(2):133
  • 4Burnier M,Brunner HR. Renal effects of angiotension 1 receptor blockade and angiotension-converting enzyme inhibiting in healthy subjects, EXP Nephrol,1996,4(Suppl 1):41
  • 5Fauvel JP,Velon S, Berra N, et al.Elects of losartan on renal function in patients with essential hypertension. Caldiovasc Pharmacol, 1996,28 (2):259

二级参考文献1

共引文献14

同被引文献6

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部